Market Cap (In USD)
8.24 Million
Revenue (In USD)
15.19 Million
Net Income (In USD)
-5.85 Million
Avg. Volume
10.28 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4.31-7.3
- PE
- -
- EPS
- -
- Beta Value
- 1.424
- ISIN
- US74019L6020
- CUSIP
- 74019L503
- CIK
- 1043961
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Ilan Danieli
- Employee Count
- -
- Website
- https://www.precipiodx.com
- Ipo Date
- 2017-06-30
- Details
- Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.
More Stocks
-
DREAMFOLKSDreamfolks Services Limited
DREAMFOLKS
-
CZMWFCarl Zeiss Meditec AG
CZMWF
-
MALUPAPERMalu Paper Mills Limited
MALUPAPER
-
7228Daytona Corporation
7228
-
URI
-
2169
-
DOTDdotdigital Group Plc
DOTD
-
1345